Risk factors for damage in childhood‐onset systemic lupus erythematosus: Cumulative disease activity and medication use predict disease damage

Citations Over TimeTop 10% of 2002 papers

Abstract

The SLICC/ACR Damage Index, though useful in childhood-onset SLE, may benefit from the introduction of weightings and redefinition of some of the items. Ongoing disease activity leads to disease damage, and treatment should be prompt. Prolonged use of high-dose corticosteroids may further increase damage, but use of immunosuppressive agents may protect against disease damage; this latter finding may have potential implications for the treatment of childhood-onset SLE and deserves further study. The relationship between disease activity and concomitant use of medication also requires further investigation.

Related Papers

• → Clinical manifestations of cutaneous lupus erythematosus(2005)175 cited
• → Drug-induced lupus erythematosus(2004)118 cited
• → Lupus Erythematosus in Childhood(1986)34 cited
• Lichen planus following procainamide-induced lupus erythematosus.(1988)
• Lupus mucinosis: a case report and review of cutaneous lupus.(2003)